- Phase I/II randomised study of a novel erythropoiesis-stimulating agent (AMG 114) for the treatment of anaemia with concomitant chemotherapy in patients with non-myeloid malignancies2011 | Publikace bez příslušnosti k fakultě
- Aspartate β-hydroxylase as a target for cancer therapy2020 | Přírodovědecká fakulta
- Aspartate beta-hydroxylase as a target for cancer therapy2020 | Přírodovědecká fakulta